Abstract
Intro: Inhaled nitric oxide is commonly utilized in pediatric hospitals for treatment of severe pulmonary hypertension in the ICU setting. Inhaled epoprostenol has been shown to be equally effective in reduction of pulmonary arterial pressures as inhaled nitric oxide and is significant less expensive. There is also data on potential deleterious side effects of long-term use of inhaled nitric oxide, including peroxynitrite and nitrogen dioxide formation. Barriers to utilizing inhaled epoprostenol include cultural norms and the lack of a refined delivery system. Aim: To decrease inhaled nitric oxide …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
